Hospital Overview

Hanaoka IVF Hospital is affiliated to the medical corporation Futaba Association. It was established in 2014 and is located in Shinagawa, Tokyo. It is a professional reproductive medical institution certified by the Japan Society of Obstetrics and Gynecology. Its predecessor was Hanaoka Women's Hospital, founded in 2006, and expanded in 2014 to an IVF hospital focusing on assisted reproduction. With the purpose of "helping patients successfully conceive in the shortest possible time", the hospital provides personalized and high-precision infertility treatment services. Hanaoka IVF Hospital is one of the few institutions in Japan that has three qualifications: PGT-A (aneuploidy screening), PGT-SR (structural abnormality screening), and PGT-M (single gene disease screening). It is also a designated unit for Japanese medical insurance and has passed ISO9001 quality management system certification; in 2024, it was awarded the "Global Health Travel Awards".
Core services and technical advantages
1

.

1. Comprehensive reproductive assisted technology
nEmbryo genetic screening
Japan averaged only 34.7%)
PGT-SR: Blocking genetic risk for couples with chromosomal structural abnormalities (such as translocations, inversions)
PGT-M: Embryo screening for monogenic diseases (such as Duchenne muscular dystrophy, spinal muscular atrophy).
Hyaluronic Acid Screening Sperm (PICSI): Screening mature sperm to improve fertilization rate and embryoquality
Follicular flushing and oocyte retrieval: Improve egg recovery rates in elderly patients, and use sedatives to reduce pain duringsurgery

2.
2. Special treatment plan
Personalizedovulation promotion regimen: Customized drug combinations (such as antagonist regimen, microstimulation regimen) based on patient age and ovarian reserve to avoid overstimulation (incidence of OHSS <1%)
SEET (thin film) transplantation method: inject embryo culture medium before transplantation to stimulate the endometrium
PRP (Platelet-rich plasma) therapy: It is used for patients with declining ovarian function (AMH<1.1 ng/ml) and thin endometrium to improve the ovarian microenvironment and receptivity.
Laboratory Equipment Configuration
Level 10,000 Clean Embryo

Laboratory

Cleanliness standard: Equipped with ULPA (Ultra-High Efficiency Air Filtration) system and independent purification power supply system, its cleanliness far exceeds Japan's national standards (Japan's Ministry of Health standard is ISO 5), effectively avoiding microbial pollution.
Cleanliness standards: Equipped with ULPA (ultra-high efficiency air filtration) systems and independent purification power supply systems. The cleanliness level far exceeds Japanese national standards (Japanese Ministry of Health’s standard is ISO 5). This effectively prevents microbial contamination.
Environmental control: The environment is maintained at a constant temperature and humidity level (temperature: 37°C, humidity: 95%), ensuring stable conditions for embryo cultivation.
Function: dynamically monitor the entire process of embryo development, automatically capture embryo morphological changes every 5 minutes, evaluate embryo division speed and abnormalities through AI algorithms, and optimize blastocyst transfer.
Function: Dynamically monitors the entire development process of embryos. Automatically captures changes in embryo morphology every 5 minutes. Uses AI algorithms to assess the rate of embryo division and any abnormalities, thereby optimizing the selection of blastocysts for transfer.
Reduce the risk of embryonic damage caused by manual intervention.
PIEZO-ICSI system: Using ultrasonic vibration microfertilization technology, sperm is sent into eggs through micro-pulse energy, avoiding negative pressure damage caused by traditional ICSI needle tip puncture, and significantly improving the fertilization rate of elderly patients or patients with poor egg quality.(>85%).
PIEZO-ICSI system: Utilizes ultrasonic micro-fertilization technology to deliver sperm into eggs using micro-pulses of energy. This approach prevents the negative pressure damage to the cytoplasm that occurs during traditional ICSI procedures. As a result, the fertilization rate for patients with advanced age or poor egg quality can be significantly improved (≥85%).
Hyaluronic acid screening technology (PICSI): This technique uses hyaluronic acid receptors to identify mature sperm, thereby reducing the risk of injecting immature sperm. As a result, the rate of successful embryo development increases by 25%.
Vitrification freezing technology: Using Japanese Cryo Bio System freezing carriers, which is much higher than the slow freezing method (<70%).

Vitrification freezing technology: Utilizes Japanese Cryo Bio System cryopreservation carriers, achieving significantly higher freezing efficiency compared to slow freezing methods (<70%).

Ifyou want to learn more about the multi-country assisted reproduction program, you can also contact the customer service ofHanaoka IVF Hospital in Japanfor free consultation. Customer service telephone: 18101365219